BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 18393325)

  • 1. Improved survival time: what can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer?
    Huang L; Cronin KA; Johnson KA; Mariotto AB; Feuer EJ
    Cancer; 2008 May; 112(10):2289-300. PubMed ID: 18393325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional survival in ovarian cancer: results from the SEER dataset 1988-2001.
    Choi M; Fuller CD; Thomas CR; Wang SJ
    Gynecol Oncol; 2008 May; 109(2):203-9. PubMed ID: 18329082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based survival-cure analysis of ER-negative breast cancer.
    Huang L; Johnson KA; Mariotto AB; Dignam JJ; Feuer EJ
    Breast Cancer Res Treat; 2010 Aug; 123(1):257-64. PubMed ID: 20130982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of breast cancer mortality rates with those of ovarian and colorectal carcinoma.
    Stearns AT; Hole D; George WD; Kingsmore DB
    Br J Surg; 2007 Aug; 94(8):957-65. PubMed ID: 17377931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CANSURV: A Windows program for population-based cancer survival analysis.
    Yu B; Tiwari RC; Cronin KA; McDonald C; Feuer EJ
    Comput Methods Programs Biomed; 2005 Dec; 80(3):195-203. PubMed ID: 16257080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rural versus urban colorectal and lung cancer patients: differences in stage at presentation.
    Paquette I; Finlayson SR
    J Am Coll Surg; 2007 Nov; 205(5):636-41. PubMed ID: 17964438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
    Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS
    Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer.
    Wethington SL; Herzog TJ; Seshan VE; Bansal N; Schiff PB; Burke WM; Cohen CJ; Wright JD
    Cancer; 2008 Dec; 113(12):3298-306. PubMed ID: 19006196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating and modeling the cure fraction in population-based cancer survival analysis.
    Lambert PC; Thompson JR; Weston CL; Dickman PW
    Biostatistics; 2007 Jul; 8(3):576-94. PubMed ID: 17021277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cure fraction estimation from the mixture cure models for grouped survival data.
    Yu B; Tiwari RC; Cronin KA; Feuer EJ
    Stat Med; 2004 Jun; 23(11):1733-47. PubMed ID: 15160405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in colorectal cancer survival: a population-based study.
    Mitry E; Bouvier AM; Esteve J; Faivre J
    Eur J Cancer; 2005 Oct; 41(15):2297-303. PubMed ID: 16140008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab.
    Gundrum JD; Mathiason MA; Moore DB; Go RS
    J Clin Oncol; 2009 Nov; 27(31):5227-32. PubMed ID: 19770371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
    Havrilesky LJ; Sanders GD; Kulasingam S; Myers ER
    Gynecol Oncol; 2008 Nov; 111(2):179-87. PubMed ID: 18722004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.
    Rim SH; Seeff L; Ahmed F; King JB; Coughlin SS
    Cancer; 2009 May; 115(9):1967-76. PubMed ID: 19235249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of T and N stage on long-term survival of rectal cancer patients in the community.
    Kozak KR; Moody JS
    J Surg Oncol; 2008 Sep; 98(3):161-6. PubMed ID: 18615481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paediatric testicular cancer: an updated review of incidence and conditional survival from the Surveillance, Epidemiology and End Results database.
    Alanee S; Shukla A
    BJU Int; 2009 Nov; 104(9):1280-3. PubMed ID: 19388997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unresectable colorectal cancer can be cured with multimodality therapy.
    Mathis KL; Nelson H; Pemberton JH; Haddock MG; Gunderson LL
    Ann Surg; 2008 Oct; 248(4):592-8. PubMed ID: 18936572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of survival curves for colorectal cancer.
    Platell CF; Semmens JB
    Dis Colon Rectum; 2004 Dec; 47(12):2070-5. PubMed ID: 15657656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of Danish cancer patients 1943-1987. Male genital organs.
    Møller H; Friis S; Kjaer SK
    APMIS Suppl; 1993; 33():122-36. PubMed ID: 8512735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.